Michael Bishop
Analyst · Cowen and Company. Your line is open
Thank you, Jason. Let’s begin by reviewing the financial metrics for the quarter shown on Slide 7. Second quarter revenue increased by 105%, compared to the second quarter of fiscal 2019 to $18.9 million. The biggest contributor was revenue from service and license agreements, which increased by $4.4 million versus the prior year quarter to $7 million. The increase was driven by revenue recorded on module replacements under customer service agreements. Revenues from generation increased by $3 million to $4.6 million in the second quarter of fiscal 2020, primarily benefiting from additional revenue associated with the Bridgeport Fuel Cell Park project that we acquired in May of 2019. And the addition of the Tulare BioMAT project, which began commercial operation in December of 2019. We had 32.6 megawatts of operating power plants in our portfolio as of April 30, 2020, compared to 11.2 megawatts at the end of the second quarter of fiscal year 2019. Increasing the scale of our generation portfolio in order to derive long-term recurring cash flows is a strategic focus of the company. Advanced – revenue from Advanced Technology contracts increased by $2.3 million to $7.3 million in the quarter due to the addition of revenues from the company’s joint development agreement with ExxonMobil Research and Engineering Company, which was executed during the first quarter of fiscal 2020 and the timing of activity under other existing contracts. Gross profit was approximately $200,000 for the quarter, compared to a gross loss of $3.6 million in the second quarter of fiscal 2019. Results benefited from increased Advanced Technology work under our joint development agreement with ExxonMobil Research and Engineering Company, as well as lower manufacturing costs, resulting from our reduction in workforce in fiscal 2019, partially offset by approximately $1 million of manufacturing variances due to the shutdown of our Torrington manufacturing facility due to COVID-19 pandemic and a loss from our generation portfolio due to maintenance repairs at several plants during the quarter. We are disappointed by the results of the generation portfolio in the quarter, which now has eight operating plants. We are striving for operational excellence across the platform and have identified improvement opportunities, which have and will be implemented in future periods. Operating expenses for the quarter decreased by $5.7 million, or 41% to $8.3 million, compared to $14 million in the same quarter of fiscal 2019. R&D expenses of $1.1 million and administrative and selling expenses of $7.2 million reflects the decreased allocation of resources to internal R&D development, lower headcount and lower legal and consulting costs. Please turn to Slide 8 for additional detail on financial performance for the quarter. Our net loss attributable to common stockholders was $15.6 million, or negative $0.07 per basic and diluted share in the second quarter of 2020, compared to a net loss attributable to common stockholders of $22.9 million, or negative $2.06 per basic and diluted share in the second quarter of 2019. The lower net loss per common share is primarily due to an increase in the weighted average shares outstanding, due to the issuances since April 30, 2019. Results for the quarter also include a non-cash mark-to-market accounting expense of $3.4 million, or approximately $0.02 per share related to the fair value liability associated with the warrants issued under our credit agreement with Orion Energy Partners. Net loss totaled $14.8 million, compared to a net loss of $19.5 million in the second quarter of last year. In the second quarter, loss from operations improved to $8.1 million, compared to a loss from operations of $17.6 million in the second quarter of fiscal 2019. Adjusted EBITDA improved to negative $3.3 million, compared to adjusted EBITDA of negative $14.5 million in the second quarter of fiscal 2019, primarily reflecting the lower expenses and improved gross profit I previously discussed. Moving to the chart in the center. As of April 30, 2020, cash, restricted cash and cash equivalents totaled $73.4 million, of which $44.3 million was restricted cash and cash equivalents. Unrestricted cash and cash equivalents, as presented on our consolidated balance sheet, includes project cash and cash equivalents borrowed under our credit agreement with Orion Energy Partners, which can only be used by our project subsidiaries for project construction, purchase of equipment and working capital for projects approved under the credit agreement. This totaled $18.6 million as of April 30, 2020, and is highlighted by the green bar in the chart. We also have unrestricted in cash and cash equivalents, which can be used by the company for general corporate purposes, including working capital at the corporate level. This balance totaled $10.5 million as of April 30, 2020, and is highlighted by the dark blue bar at the bottom of the chart. This includes proceeds of the PPP Note received during the quarter. In total, as of April 30, 2020, unrestricted cash and cash equivalents equaled approximately $29.1 million, compared to $9.4 million as of April 31, 2019. During the quarter, we completed the $14.4 million sale-leaseback transaction with Crestmark Equipment Finance for the 2.8-megawatt biogas fueled fuel cell power plant, located at the wastewater treatment plant in Tulare, California. Additionally, under the CARES Act created in response to the COVID-19 pandemic, in April, we entered into a Paycheck Protection Program loan, or PPP Note and received total proceeds of approximately $6.5 million. In accordance with the requirements of the CARES Act, the company is using the proceeds primarily for payroll costs. As we previously disclosed, we have taken steps to prioritize the health and safety of our team members by temporarily suspending operations at our Torrington manufacturing facility, and we have not implemented any furlough, layoff or shared work programs. Excluding project cash and cash equivalents and the remaining balance of approximately $6 million under the PPP Note, unrestricted cash and cash equivalents totaled $4.5 million as of April 30, 2020, compared to $9.4 million as of October 31, 2019. Finally, turning to the backlog chart on the right side of the slide, we finished the quarter with backlog of $1.34 billion. This is an $80.8 million increase over the end of the second quarter of fiscal 2019. Total backlog is comprised of $1.1 billion for generation, $183 million for service and license and $57 million under Advanced Technology contracts. Next, turning to Slide 9, I would like to highlight some of the recent steps we have taken to provide additional liquidity to execute on our business plan, which includes building out our backlog of generation projects. Under our business model, as projects become operational, we expect to close on long-term financing at an efficient cost of capital, which recycles cash back to the company to be used to pay down the Orion credit facility or to be redeployed into other projects with the consent of the agent and the lender under the Orion Facility. An example of this occurred in the quarter, whereby in February, we closed on the 10-year sale-leaseback financing transaction with Crestmark Equipment Finance. This transaction has allowed us to retain the Tulare BioMAT project in our generation portfolio, which in turn, provides long-term return recurring cash flows. $6.5 million of the net proceeds from this transaction were deposited into the Orion project proceeds account, which is a restricted cash account on the company’s balance sheet. These proceeds are for future distribution at the discretion of the agent and the lenders under the Orion Facility to construct our projects, for working capital support or for repayment of principal due to Orion. Later in the quarter, on April 30, we entered into the fourth amendment of the Orion credit agreement, which permitted the release of up to $3.5 million of restricted cash from the project proceeds account to be used to fund construction of the company’s 1.4-megawatt biogas fuel project at the wastewater treatment plant in San Bernardino, California, which began construction this quarter. $2.3 million of the proceeds were released subsequent to quarter-end and the balance may be released by Orion when the company achieves certain project milestones. Once this project achieves commercial operation, we expect to source long-term financing for the asset, which would again recycle capital back to the business to pay down on Orion or be redeployed into other projects with the consent of the agent and the lender under the Orion Facility. Finally, on the slide, subsequent to quarter-end, in order to alleviate substantial doubt about the company’s ability to continue as a going concern, today, we are announcing that we have entered into a $35 million secondary financing facility through a fifth amendment to our existing $200 million credit agreement with Orion Energy Partners. Pursuant to the fifth amendment, the lenders have committed to make a secondary facility loans of up to an aggregate amount of $35 million available to the company for general corporate purposes. These loans may be drawn down between now and September 14, 2020. Any drawn amounts may be fully repaid on or before September 1 2021. In exchange for this new loan commitment, the company will pay to the lenders an option premium of $1 million on the earlier of September 14, 2020, and the date of full repayment of all amounts drawn under the facility. Additionally, for each draw made on the secondary facility loans, the company shall pay the lenders an initial draw discount of 5% of the amount drawn. In the event that full repayment of all amounts drawn under the secondary facility loans has not occurred within six months of the initial draw. The company must pay the lenders an additional draw discount in the amount of 10% of any amount outstanding as of such date. In the event that full repayment has not occurred within nine months of the date of the initial draw, the company must pay the lenders an additional draw discount in the amount of 20% of any amount outstanding at such date. In connection with Orion making this new commitment, the company is providing additional collateral to the lenders by a pledge of the company’s intellectual property assets. All leans on the company’s intellectual property will be released upon full payment of all amounts drawn on the secondary facility loans or upon termination of the commitment if no amounts are drawn. The company is required to prepay any draws on the secondary facility in advance that the company issues or incurs any new indebtedness other than permitted indebtedness as defined in the Orion credit agreement or issues or sells equity, which includes any capital stock or any instrument security or right that is convertible into or exercisable or exchangeable for capital stock. Under these two scenarios, 100% of the net proceeds of any new debt issuance and 50% of the – of net proceeds of any equity issuance must be applied to pay down the outstanding amounts under the secondary facility loans. A complete description of the fifth amendment is included in our second quarter 10-Q, which was filed this morning. In addition to this new financing with Orion, the company continues to – I’m sorry, in addition to this new facility with Orion, the company continues to evaluate new debt and equity financing options as we execute on our Powerhouse business strategy across all of our product and technology platforms. To wrap up my comments, on balance, we are pleased with the overall progress that we made in the quarter in a challenging business environment. We look forward to continuing to execute against our backlog, as well as other future growth opportunities as we emerge from the pandemic. I will now turn the call back over to Jason.